)
Picard Medical (PMI) investor relations material
Picard Medical Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Completed IPO in September 2025, raising $19.55 million gross ($15.2 million net), strengthening the balance sheet by retiring convertible debt and funding operations, R&D, market expansion, and debt repayment.
Focused on commercializing the SynCardia Total Artificial Heart, the only FDA-approved total artificial heart in the US, with over 2,100 implants globally.
Expanded patent portfolio with new patents in the US and China for next-generation artificial heart technology.
Strengthened board independence with the appointment of two new independent directors with expertise in capital markets and medical devices.
Continues to invest in next-generation devices and expects ongoing operating losses as it scales up revenue.
Financial highlights
Total revenue for the nine months ended September 30, 2025, was $3.93 million, up 11% year-over-year, with Q3 2025 revenue at $1.19 million, up 35% year-over-year, driven by US product sales and increased driver rentals.
Net loss for the nine months was $22.7 million, including $12.4 million in non-cash charges from derivative liabilities related to convertible debt conversion at IPO.
Gross loss for the nine months widened to $0.6 million, but Q3 2025 gross loss narrowed by 81% to $0.13 million as cost of revenue declined 15% year-over-year.
Operating loss for the nine months was $10.3 million, nearly flat year-over-year, while Q3 2025 operating loss narrowed to $3.36 million from $3.77 million in Q3 2024.
Cash and cash equivalents at September 30, 2025, were $2.8 million.
Outlook and guidance
Management expects continued operating losses and negative cash flows until revenue growth offsets fixed costs and R&D investments.
Substantial doubt exists about the ability to continue as a going concern without additional capital; IPO proceeds expected to fund operations into 2025.
New capital from the IPO is expected to accelerate research, development, and commercial expansion of the artificial heart platform.
Next Picard Medical earnings date
Next Picard Medical earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage